A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease-Reference-Cited by-同舟云学术

A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease

Published:2010-09 Issue:9 Volume:18 Page:1731-1735
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Muramatsu Shin-ichi,Fujimoto Ken-ichi,Kato Seiya,Mizukami Hiroaki,Asari Sayaka,Ikeguchi Kunihiko,Kawakami Tadataka,Urabe Masashi,Kume Akihiro,Sato Toshihiko,Watanabe Eiju,Ozawa Keiya,Nakano Imaharu

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference22 articles.

1. The history of dopamine and levodopa in the treatment of Parkinson's disease;Fahn;Mov Disord,2008

2. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects;Nagatsu;J Neural Transm Suppl,2007

3. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach;Bankiewicz;Exp Neurol,2000

4. Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC;Bankiewicz;Mol Ther,2006

5. Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes;Muramatsu;Hum Gene Ther,2002

Cited by 277 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for polygenic or complex diseases;Biomarker Research;2024-09-04

2. Emerging Gene Therapies for Alzheimer’s and Parkinson’s Diseases: An Overview of Clinical Trials and Promising Candidates;Cureus;2024-08-16

3. Potential Therapeutic Approach using Aromatic l-amino Acid Decarboxylase and Glial-derived Neurotrophic Factor Therapy Targeting Putamen in Parkinson's Disease;Current Gene Therapy;2024-08

4. Intraparenchymal delivery of adeno-associated virus vectors for the gene therapy of neurological diseases;Expert Opinion on Biological Therapy;2024-07-31

5. Codon-Optimized and de novo–Synthesized E-Selectin/AAV2 Dose–Response Study for Vascular Regeneration Gene Therapy;Annals of Surgery;2024-07-08